Table 2.

Additional features of patients, some of which are used for exploratory data analysis

Groups	Patient number	Sex	Age group	REGN-COV treatment	wild type	delta	omicron
Non-infected/non-vaccinated	026	M	51–60	–	1.45	1.72	1.39
	037	F	51–60	–	0.65	1.18	0.12
Infected/non-vaccinated	005	F	71–80	Yes	6.01	5.85	2.14
	019	F	31–40	–	3.58	4.07	3.68
	012	M	61–70	–	3.36	4.05	3.41
	010	F	61–70	–	3.35	4.00	2.96
	002	M	61–70	–	3.30	4.34	2.46
	015	M	51–60	–	3.11	3.75	2.92
	023	F	51–60	–	2.51	3.43	2.41
	014	M	41–50	–	2.25	2.57	1.96
Non-infected/vaccinated	020	F	61–70	–	4.23	3.76	3.54
	013	M	71–80	–	3.49	3.42	3.45
	021	M	51–60	–	3.04	3.39	3.02
	029	F	71–80	–	3.04	3.16	2.21
	022	M	51–60	–	3.00	3.84	3.40
	042	F	71–80	–	2.93	3.46	3.36
	040	M	>80	–	2.70	3.08	2.51
	028	M	21–30	–	2.48	2.78	2.47
	039	M	71–80	–	2.37	2.99	2.66
	027	F	71–80	–	2.23	2.80	2.04
	031	M	61–70	–	2.15	2.78	2.38
	034	F	>80	–	2.13	2.69	2.05
	043	M	>80	–	2.09	2.51	2.30
	049	F	51–60	–	2.09	2.35	1.68
	018	M	51–60	–	2.00	2.12	1.74
	001	M	51–60	–	1.98	2.42	1.62
	046	M	51–60	–	1.86	1.98	1.50
	041	M	71–80	–	1.64	2.11	1.81
	024	F	41–50	–	1.53	2.05	1.61
	038	F	51–60	–	1.08	1.85	1.11
Infected/vaccinated	004	F	71–80	–	4.32	3.23	2.40
	003	M	>80	Yes	4.24	5.85	4.21
	050	M	71–80	Yes	4.20	4.06	1.39
	011	M	31–40	–	4.06	4.07	3.63
	016	M	61–70	Yes	4.02	5.85	1.24
	017	M	>80	–	3.83	3.99	3.68
	007	F	>80	–	3.83	5.85	4.23
	006	M	41–50	Yes	3.78	3.99	3.11
	009	F	71–80	–	3.06	4.06	2.75
	008	M	51–60	–	2.79	3.01	2.76
	025	F	>80	–	2.61	3.62	2.40

Sex: male (M) or female (F). Age was partitioned into age groups for this table. The p(EC₅₀) values of IgG against wild type, delta, and omicron RBD are shown, rounded to two decimal places. More features of the same dataset are part of a manuscript recently published.¹